AI assistant
ALBEMARLE CORP — Director's Dealing 2025
Jan 3, 2025
30590_dirs_2025-01-03_5c08a13f-cae5-4dd6-aec8-e9a7bd3b3eb3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ALBEMARLE CORP (ALB)
CIK: 0000915913
Period of Report: 2024-12-31
Reporting Person: Masters J Kent (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | Common Stock | M | 434 | — | Acquired | 105356 | Direct |
| 2024-12-31 | Common Stock | F | 192 | $86.08 | Disposed | 105164 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | Restricted Stock Units | $ | M | 434 | Disposed | Common Stock (434) | Direct |
Footnotes
F1: The Reporting Person's holdings reported in Table 1, Column 5 include: 10,020 Restricted Stock Units ("RSUs") granted on February 24, 2023, and 21,155 RSUs granted on February 22, 2024, which were previously reported in Table 2 in Forms 4 filed 2/28/2023 and 2/26/2024, respectively. These RSUs
will vest 100% on the earlier of 12/31/2025 or the date a successor Chief Executive Officer commences employment with the Issuer (subject to the terms of the applicable award agreement). Starting with this report, RSUs subject to time-based vesting conditions will be reported in Table 1 at grant and in Column 5 as beneficially owned for consistency in reporting methodology amongst reporting persons of the Issuer.
F2: Shares withheld to meet tax liabilities associated with vesting of RSUs.
F3: Each RSU converts to 1 share of Common Stock.
F4: RSUs granted on 02/25/2022. 95% vested on 12/31/2023 and remaining 5% vested on 12/31/2024.
F5: No expiration date.